trending Market Intelligence /marketintelligence/en/news-insights/trending/pzrw01hlrfwdkvcfsz-vqa2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Immune Design director resigns

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Immune Design director resigns

Immune Design Corp. said Peter Svennilson resigned as the company's director, effective Aug. 31.

Svennilson joined the company's board in March 2013. Immune Design noted that his resignation was not due to any disagreement with the company's operations, policies or practices.

Seattle-based Immune Design is an immunotherapy company developing in vivo cancer treatments.